More access to affordable ARVs may depend on a bill

... allowing poor countries to disregard these pharmaceutical patents on account of public health emergencies such as HIV/AIDS. The grace period for manufacturing generic pharmaceuticals expires on January 1, 2016 unless the Parliament sits today and ...

http://www.newvision.co.ug/news/646324-more-access-to-affordable-arvs-may-depend-on-a-bill.html